ストックスクリーナーアプリを入手
4.99
1.77%
-0.09
前日終値:
$5.08
開ける：
$5.15
24時間の取引高:
503.18K
Relative Volume:
0.48
時価総額：
$370.48M
収益：
-
当期純損益:
$-96.66M
株価収益率:
-2.3209
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+0.40%
1か月 パフォーマンス:
-9.27%
6か月 パフォーマンス:
-59.76%
1年 パフォーマンス:
-64.02%
1日の値動き範囲:
$4.94
$5.21
1週間の範囲:
$4.935
$5.34
52週間の値動き範囲:
$4.60
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
4.99 | 370.48M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Olema's Breast Cancer Breakthrough Transform Patient Care? CEO Reveals Latest Data - StockTitan
Mehta named CMO, Greenberg CBO at Nura Bio - BioCentury
Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary - GlobeNewswire
Key Executive Hire: Biotech Veteran with 20-Year Track Record Joins Olema's C-Suite - StockTitan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 5.4%Should You Sell? - MarketBeat
Olema Pharmaceuticals: Interesting But Undifferentiated Data (NASDAQ:OLMA) - Seeking Alpha
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Slashes -5.36%: What Could Be On The Way Going Forward? - Stocks Register
SG Americas Securities LLC Has $102,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
OLMA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Upward Trajectory: Olema Pharmaceuticals Inc (OLMA) Posts a Slidee, Closing at 5.69 - The Dwinnex
The Significance of Moving Averages in Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance - The InvestChronicle
There is no way Olema Pharmaceuticals Inc (OLMA) can keep these numbers up - SETE News
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Olema Pharma's Strategic Talent Acquisition: $1.7M in Equity Grants Signals Growth Push - StockTitan
Olema Pharmaceuticals Inc (OLMA) Becoming More Attractive for Investors - Knox Daily
Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News
Financial Metrics Exploration: Understanding Olema Pharmaceuticals Inc (OLMA) Through Ratios - The Dwinnex
Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Exclusive Access: Olema Pharmaceuticals Reveals Latest Oncology Progress at Two Elite Healthcare Forums - StockTitan
HR Positive/ HER2 Negative Breast Cancer Pipeline 2024: MOA - openPR
How To Trade (OLMA) - Stock Traders Daily
JPMorgan Chase & Co. Buys 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Purchases 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Holdings Increased by Hennion & Walsh Asset Management Inc. - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $27.00 Consensus Target Price from Brokerages - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Form 424B5 Olema Pharmaceuticals, - StreetInsider.com
Barclays PLC Purchases 48,614 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Bain Capital Life Sciences Investors, LLC Acquires Significant S - GuruFocus.com
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Major Shareholder Acquires $1,728,000.00 in Stock - MarketBeat
Bain Capital Life Sciences buys $1.7m in Olema Pharmaceuticals stock - Investing.com Nigeria
Olema Pharmaceuticals announces equity security exchange By Investing.com - Investing.com Australia
Olema Pharmaceuticals announces equity security exchange - Investing.com India
Olema Pharmaceuticals stock hits 52-week low at $5.02 - Investing.com India
Olema Pharmaceuticals stock hits 52-week low at $5.02 By Investing.com - Investing.com South Africa
(OLMA) Investment Report - Stock Traders Daily
Olema Pharmaceuticals Awards New Employee Stock Options for Cancer Drug Development Team - StockTitan
Olema Pharmaceuticals stock hits 52-week low at $5.55 By Investing.com - Investing.com Australia
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):